Healthcare, Pharma & Life Sciences

Roche Wins FDA Approval for First IHC Companion Diagnostic to Detect PTEN Protein Loss in Prostate Cancer

Image
FDA Grants Priority Review for Roche's Tecentriq in Stage III dMMR Colon Cancer After Surgery

SHERIDAN, WYOMING -- June 14, 2026 -- Roche has received FDA approval for the VENTANA PTEN (SP218) RxDx Assay, the first immunohistochemistry companion diagnostic cleared to assess PTEN protein loss in patients with prostate adenocarcinoma. The assay identifies patients whose tumours exhibit PTEN deficiency, making them potentially eligible for treatment with AstraZeneca's TRUQAP in combination with abiraterone acetate. Approval is based on results from the CAPItello-281 clinical study, where the assay served as the enrollment diagnostic to identify patients with PTEN-deficient tumours.

FDA Grants Priority Review for Roche's Tecentriq in Stage III dMMR Colon Cancer After Surgery

Image
FDA Grants Priority Review for Roche's Tecentriq in Stage III dMMR Colon Cancer After Surgery

SHERIDAN, WYOMING -- June 14, 2026 -- The U.S. Food and Drug Administration has accepted Roche's supplemental Biologics License Application for Tecentriq and Tecentriq Hybreza in combination with chemotherapy as an adjuvant treatment for stage III dMMR/MSI-H colon cancer following surgery. The FDA has granted Priority Review and is expected to issue a decision by June 14, 2026. The filing is supported by Phase III ATOMIC study data showing a 50% reduction in the risk of disease recurrence or death compared to chemotherapy alone, results published in The New England Journal of Medicine.

Dentsply Sirona Launches WaveOne® Gold Orifice Shaper for Single-Motor Coronal Flaring in the U.S. and Canada

Image
Dentsply Sirona Launches WaveOne® Gold Orifice Shaper for Single-Motor Coronal Flaring in the U.S. and Canada

SHERIDAN, WYOMING -- June 14, 2026 -- Dentsply Sirona has launched the WaveOne® Gold Orifice Shaper, its first reciprocating coronal flaring instrument, now available in the United States and Canada. The file is designed to integrate directly into the existing WaveOne® Gold treatment protocol, using the same reciprocating motion and motor settings as the rest of the system. That compatibility eliminates the need to change motor configurations during root canal preparation — a practical workflow improvement that reduces procedural complexity and the risk of operator error.

Philips VeriSight Pro 3D ICE Brings Real-Time Imaging Inside the Heart to Advance Minimally Invasive Structural Procedures

Image
Philips VeriSight Pro 3D ICE Brings Real-Time Imaging Inside the Heart to Advance Minimally Invasive Structural Procedures

SHERIDAN, WYOMING -- June 09, 2026 -- Philips has put its VeriSight Pro 3D intracardiac echocardiography (ICE) technology in front of a wider audience through a feature on the BBC's technology program Tech Now, filmed during a live structural heart procedure in Copenhagen. The technology places a miniature ultrasound probe on the tip of a catheter, threading it through a vein into the heart to deliver real-time three-dimensional images of anatomy, valves, and treatment devices. For interventional teams, it offers an alternative to passing a larger probe down the patient's esophagus under general anaesthesia. The result is a more precise and less invasive route to treating structural heart disease.

Philips Future Health Index 2026 Finds AI Saving Clinicians 16 Working Days a Year as Training Gaps Persist

Image
Philips Future Health Index 2026 Finds AI Saving Clinicians 16 Working Days a Year as Training Gaps Persist

SHERIDAN, WYOMING -- June 09, 2026 -- Philips has released its Future Health Index 2026, the 11th edition of its annual global study, drawing on responses from more than 2,000 healthcare professionals and over 20,000 patients across 10 countries. The findings show that artificial intelligence already saves clinicians the equivalent of more than 16 working days each year and is helping many of them treat additional patients. At the same time, the report warns that inadequate training and fragmented IT infrastructure could leave some health systems behind. For hospital leaders and care providers, the results frame AI less as a future prospect and more as an operational tool already reshaping daily workloads.

Ivoclar Publishes Three Clinical Tips for Combining Tetric plus Flow and Fill in Anterior and Class V Restorations

Image
Ivoclar Publishes Three Clinical Tips for Combining Tetric plus Flow and Fill in Anterior and Class V Restorations

SHERIDAN, WYOMING -- June 07, 2026 -- Ivoclar has published clinical practice guidance for dental professionals working with the Tetric plus composite system, focusing on combined workflows involving Tetric plus Flow and Tetric plus Fill in anterior restorations. The guidance positions Tetric plus Flow as a single-material replacement for both Tetric EvoFlow and Tetric PowerFlow, built around its thixotropic properties — controlled, precise application alongside strong flow when required. Three tips address contouring support, surface imperfection repair and volume or transition adjustment in Class IV, Class V and direct veneer procedures. OptraSculpt Pad and OptraGloss are recommended as supporting instruments throughout.

Henry Schein Elects Dan Daniel as Independent Board Chairman as Stanley Bergman Retires After Four Decades

Image
Henry Schein Elects Dan Daniel as Independent Board Chairman as Stanley Bergman Retires After Four Decades

SHERIDAN, WYOMING -- June 06, 2026 -- Henry Schein, Inc. has elected William K. "Dan" Daniel as Independent Chairman of the Board effective June 06, 2026, as Stanley M. Bergman steps down following 44 years as a Director of the company. Daniel joined the Henry Schein board in May 2025 and brings executive leadership experience across healthcare and industrial businesses, including a 14-year tenure as Executive Vice President at Danaher Corporation. The election places a leader with direct experience in dental sector governance and operations in the chair role at the world's largest provider of healthcare solutions to office-based dental and medical practitioners. Bergman has been named Chairman Emeritus.

Dentsply Sirona Primescan 2 Cart Wins 2026 iF Design Award for Digital Dentistry Workflow Design

Image
Dentsply Sirona Primescan 2 Cart Wins 2026 iF Design Award for Digital Dentistry Workflow Design

SHERIDAN, WYOMING - May 19, 2026 - Dentsply Sirona has announced that its Primescan 2 Cart has received the 2026 iF Design Award in the Product Design - Medicine / Health category, recognizing its ergonomic engineering, clinician-focused usability, and integration into cloud-based digital dental workflows. The award highlights the system's role in supporting more mobile, connected intraoral scanning environments as digital dentistry adoption continues to expand globally. The recognition also reflects increasing industry emphasis on workflow efficiency, portability, and system integration within modern dental practices transitioning toward cloud-native clinical infrastructure.

Philips Launches SmartIQ to Reduce Radiation-Image Quality Trade-Off in Coronary Interventions

Image
Philips Launches SmartIQ to Reduce Radiation-Image Quality Trade-Off in Coronary Interventions

SHERIDAN, WYOMING - May 19, 2026 - Royal Philips has introduced SmartIQ, a new coronary imaging technology integrated into its Azurion image-guided therapy platform, designed to address a long-standing clinical challenge in interventional cardiology: balancing high image quality with reduced radiation exposure. The system was developed with cardiovascular centers and focuses on ultra-low dose imaging protocols that maintain diagnostic clarity while lowering X-ray exposure for patients and clinical staff. Philips is positioning the technology as part of a broader strategy to strengthen workflow consistency, evidence generation, and dose optimization in coronary procedures, with initial clinical validation already underway through published pilot studies and ongoing multicenter research programs.

Philips Expands AI-Guided Cardiology Workflow Strategy With Low-Dose Imaging Innovations at EuroPCR 2026

Image
Philips Expands AI-Guided Cardiology Workflow Strategy With Low-Dose Imaging Innovations at EuroPCR 2026

SHERIDAN, WYOMING - May 19, 2026 - Royal Philips is using EuroPCR 2026 in Paris to present an expanded portfolio of imaging, physiology and AI-enabled workflow technologies aimed at supporting increasingly complex percutaneous coronary intervention (PCI) and structural heart procedures. The company's latest developments focus on integrating imaging systems, physiological assessment tools and procedural guidance into a unified interventional cardiology workflow while also addressing radiation exposure concerns in catheterization laboratories. Philips is positioning the strategy around operational efficiency, procedural confidence and lower-dose imaging as healthcare providers manage rising procedural complexity and increased pressure on cath lab performance.